Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioanalytical profiling of Avonex in MS
NCT00913666Phase 4Completed
- Sponsor
- Biogen
- Start
- Nov 2002
- Modality
- Cytokines & Interferons
01
Overview
A Phase 4 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Biogen. Started Nov 2002; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00913666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913666.